Antibody which is directed against galectin-9 and is an inhibitor of the suppressor activity of regulatory T lymphocytes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10899838
APP PUB NO 20170283499A1
SERIAL NO

15316074

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to an antibody which is directed against galectin-9 and is an inhibitor of the suppressor activity of regulatory T lymphocytes, and also to the use of this antibody for the treatment of diseases associated with the suppressor activity of regulatory T lymphocytes, in particular the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITÉ PARIS-SACLAYPARC TECHNOLOGIQUE IMMEUBLE DISCOVERY ROUTE DE L'ORME AUX MERISIERS RD 128 SAINT AUBIN 91190

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barjon, Clement Villejuif, FR 2 15
Busson, Pierre Antony, FR 19 118
Delhem, Nadira Marcq en Baroeul, FR 2 15
Lhuillier, Claire Le Kremlin-Bicetre, FR 2 15
Morales, Olivier Lille, FR 4 30
Mrizak, Dhafer Lille, FR 2 15
Mustapha, Rami Lille, FR 2 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 26, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 26, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00